<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="iso-abbrev">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="publisher-id">ECAM</journal-id><journal-title-group><journal-title>Evidence-based Complementary and Alternative Medicine : eCAM</journal-title></journal-title-group><issn pub-type="ppub">1741-427X</issn><issn pub-type="epub">1741-4288</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24971148</article-id><article-id pub-id-type="pmc">4058151</article-id><article-id pub-id-type="doi">10.1155/2014/495274</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Effects of Qigong Training on Health-Related Quality of Life, Functioning, and Cancer-Related Symptoms in Survivors of Nasopharyngeal Cancer: A Pilot Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Fong</surname><given-names>Shirley S. M.</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Ng</surname><given-names>Shamay S. M.</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Luk</surname><given-names>W. S.</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Chung</surname><given-names>Louisa M. Y.</given-names></name><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wong</surname><given-names>Janet Y. H.</given-names></name><xref ref-type="aff" rid="I5">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Chung</surname><given-names>Joanne W. Y.</given-names></name><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Institute of Human Performance, University of Hong Kong, Pokfulam, Hong Kong</aff><aff id="I2"><sup>2</sup>Department of Rehabilitation Sciences, Hong Kong Polytechnic University, Hung Hom, Hong Kong</aff><aff id="I3"><sup>3</sup>The Association of Licentiates of the Medical Council of Hong Kong, Hong Kong</aff><aff id="I4"><sup>4</sup>Department of Health and Physical Education, Hong Kong Institute of Education, Tai Po, Hong Kong</aff><aff id="I5"><sup>5</sup>School of Nursing, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong</aff><author-notes><corresp id="cor1">*Shirley S. M. Fong: <email>smfong@hku.hk</email></corresp><fn fn-type="other"><p>Academic Editor: Manuel Arroyo-Morales</p></fn></author-notes><pub-date pub-type="ppub"><year>2014</year></pub-date><pub-date pub-type="epub"><day>28</day><month>5</month><year>2014</year></pub-date><volume>2014</volume><elocation-id>495274</elocation-id><history><date date-type="received"><day>30</day><month>4</month><year>2014</year></date><date date-type="accepted"><day>14</day><month>5</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 Shirley S. M. Fong et al.</copyright-statement><copyright-year>2014</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/3.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>This study aimed to investigate the effects of Qigong intervention on quality of life (QOL), health-related functioning, and cancer-related symptoms in survivors of nasopharyngeal cancer (NPC). Twenty-five survivors of NPC were included in the experimental group (mean age &#x000b1; SD: 55.4 &#x000b1; 7.5 years) and 27 in the control group (mean age &#x000b1; SD: 58.7 &#x000b1; 9.5 years). The experimental group underwent a weekly 1.5-hour Qigong training program and an identical home program (three times/week) for six months. The control group received no training. Global health status/QOL, functioning, and cancer-related symptoms were assessed by the European Organization for Research and Treatment of Cancer QLQ-C30 and QLQ-H&#x00026;N35 questionnaires before training began, after three months of Qigong training, at the end of the six-month Qigong intervention (i.e., posttest), and six months posttest. Intention-to-treat analysis revealed no statistically (<italic>P</italic> &#x0003e; 0.05) or clinically significant improvement in global health status/QOL, functioning, or symptoms in either group. The experimental group had 45.8% fewer sense-related (smell and taste) problems (<italic>P</italic> &#x0003c; 0.05) but 98.6% more speech-related problems (<italic>P</italic> &#x0003c; 0.05) than the control group after the Qigong intervention. Qigong training resulted in no apparent improvement in health-related QOL, functionality, or cancer-related symptoms in cancer-free survivors of NPC, except for a possible reduction in smell- and taste-related problems.</p></abstract><funding-group><award-group><funding-source>University of Hong Kong</funding-source><award-id>201308159012</award-id></award-group><award-group><funding-source>Hong Kong Institute of Education</funding-source><award-id>RG57/2012-2013R</award-id></award-group></funding-group></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>
Many people in Southeast Asia, Southern China, and North Africa are diagnosed with nasopharyngeal cancer (NPC), a disease endemic in these regions [<xref rid="B1" ref-type="bibr">1</xref>]. The incidence rate is high in these areas, ranging from 25 to 50 per 100,000 persons [<xref rid="B1" ref-type="bibr">1</xref>]. Although advances in NPC treatments have led to improvements in survival rates (five-year survival rate = 55%&#x02013;90%) [<xref rid="B2" ref-type="bibr">2</xref>], survivors often live with numerous cancer- or treatment-related symptoms that cause dysfunctions and a reduction in quality of life (QOL) [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>]. A previous study reported that survivors of NPC had a lower health-related QOL during their cancer-free survival period than the healthy control participants. Socioeconomic status was the major determinant of QOL in this group. Participants who had a lower economic status tended to have a lower QOL [<xref rid="B3" ref-type="bibr">3</xref>]. It is thus necessary to identify low-cost remedial strategies to improve QOL and reduce adverse side effects in survivors of NPC.</p><p>Qigong is a low-cost mind-and-body exercise that originated in China. It comprises meditation, coordinated breathing, and graceful bodily movements [<xref rid="B5" ref-type="bibr">5</xref>]. There is some evidence that Qigong can improve QOL and reduce side effects of cancer treatment [<xref rid="B6" ref-type="bibr">6</xref>&#x02013;<xref rid="B8" ref-type="bibr">8</xref>]. Several studies have reported the positive effects of Qigong training on global QOL as measured by the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire 30 (QLQ-C30) [<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>]. Cancer treatment side effects, such as constipation [<xref rid="B7" ref-type="bibr">7</xref>] and inflammation, were reduced [<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>] and perceived cognitive abilities improved [<xref rid="B8" ref-type="bibr">8</xref>]. These promising results reported in cancer patients raised the possibility that survivors of NPC may also benefit from Qigong training after the conventional treatment period. To date, no study has examined the effect of Qigong intervention on residual cancer- or treatment-related side effects and QOL in NPC survivors, who tend to be young and active members of the workforce [<xref rid="B2" ref-type="bibr">2</xref>].</p><p>The aim of this prospective, nonrandomized, and controlled trial was to investigate the effects of Qigong training on health-related QOL, functions, and cancer-related symptoms in survivors of NPC. The research hypotheses of this study were (1) improvements in QOL and functioning and a reduction in symptoms should be observed in the experimental group across the four assessment time points (i.e., pretest, midintervention, posttest, and follow-up) and (2) the experimental group should have better QOL, higher functions, and fewer cancer-related symptoms than the control group immediately after Qigong intervention and also at the six-month follow-up point.</p></sec><sec id="sec2"><title>2. Methods</title><sec id="sec2.1"><title>2.1. Participants</title><p>Survivors of NPC were recruited from a medical clinic and a cancer self-help group by convenience sampling. They were first screened by a medical doctor to ensure that inclusion and exclusion criteria were met. The inclusion criteria were as follows: (1) individuals had a history of NPC (i.e., positive Epstein-Barr virus DNA and biopsy test results) but were free from the disease during the study period; (2) had completed all cancer treatments (e.g., chemotherapy and radiotherapy) although conventional medical care was allowed; (3) were medically stable; (4) aged between 40 and 85 years; (5) had expected survival period of more than one year; (6) spoke Cantonese; (7) residing in Hong Kong; (8) had normal cognitive function; and (9) could read Chinese. The exclusion criteria were (1) receiving alternative and complementary therapies (e.g., traditional Chinese medicine); (2) having significant chronic medical conditions such as uncontrolled hypertension; (3) having significant neurological, musculoskeletal, cardiopulmonary, or vascular disorders; (4) ambulating dependently; and (5) smoking. Ethical approval was obtained from the ethics review committee of the administering institutes. Written informed consent was obtained from each participant prior to data collection. All procedures were conducted according to the Declaration of Helsinki principles.</p></sec><sec id="sec2.2"><title>2.2. Intervention</title><p>The intervention group received weekly 1.5-hour face-to-face Qigong training continuously for six months. The traditional 18 Forms Tai Chi Internal Qigong [<xref rid="B5" ref-type="bibr">5</xref>] and NPC-targeted exercises were included in the Qigong training program (<xref ref-type="table" rid="tab1">Table 1</xref>). This training protocol specific for survivors of NPC was designed by a medical doctor and a Qigong master. It places more emphasis on the olfactory, inner ear, and oral stimulations when compared to the traditional Qigong forms. Similar to other Qigong training regimes, our training program emphasized meditation, coordinated breathing, and slow and smooth Tai Chi movements. Participants progressively learned one to two new techniques in each face-to-face session (<xref ref-type="table" rid="tab1">Table 1</xref>). A certified Qigong instructor and an assistant instructor delivered all the Qigong classes. Moreover, a Qigong home program was prescribed to the intervention group to increase the training frequency to four times per week in total. The home exercises were exactly the same as those learned in the supervised sessions. The Qigong instructors checked the participants' compliance to the home program by asking and testing them every week to ensure that the training volume was adequate. All participants stopped practicing Qigong during the follow-up period. The control group received no Tai Chi or Qigong training but continued to receive conventional medical care if necessary throughout the whole study period.</p></sec><sec id="sec2.3"><title>2.3. Outcome Measurements</title><p>Demographic characteristics, habitual physical activity level (metabolic equivalent hours per week), and medical history of the participants were obtained at pretest (<xref ref-type="table" rid="tab2">Table 2</xref>). In addition, all of the participants were required to complete two questionnaires&#x02014;EORTC QLQ-C30 and the head and neck cancer supplementary module (QLQ-H&#x00026;N35)&#x02014;to evaluate their global health status/QOL, functioning and cancer-related symptoms one week before the Qigong intervention (pretest), after three months of Qigong training (midintervention test), immediately after the six-month Qigong intervention (posttest), and six months posttest (follow-up test).</p><p>The EORTC QLQ-C30 (version 3.0 for the Hong Kong Chinese population) and the QLQ-H&#x00026;N35 (Hong Kong Chinese version) were used together as originally designed [<xref rid="B9" ref-type="bibr">10</xref>]. These self-administered questionnaires were validated for the Hong Kong Chinese population and their psychometric properties are considered to be satisfactory [<xref rid="B10" ref-type="bibr">11</xref>, <xref rid="B11" ref-type="bibr">12</xref>]. The QLQ-C30 questionnaire, suitable for a board range of cancer patients and survivors, comprises 30 items assessing health-related QOL. It is composed of one global health status/QOL scale, five functional scales (i.e., physical, role, cognitive, emotional, and social), three symptom scales (i.e., fatigue, nausea and vomiting, and pain), and six single items (i.e., dyspnea, insomnia, appetite loss, constipation, diarrhea, and financial difficulties). Items on the functional and symptom scales were scored with a four-point Likert scale (1 = not at all, 2 = a little, 3 = quite a bit, and 4 = very much) while items in the global health status/QOL domain were scored on a seven-point Likert scale, ranging from 1 (very poor) to 7 (very good) [<xref rid="B9" ref-type="bibr">10</xref>].</p><p>The QLQ-H&#x00026;N35 module was used to assess symptoms specifically in head and neck cancer patients and survivors. It consists of 35 items in total that were scored with a four-point Likert scale (1 = not at all, 2 = a little, 3 = quite a bit, and 4 = very much). Seven scales assess symptoms of pain, swallowing, senses (smell/taste), speech, social eating, social contact, and sexuality, and six single items assess the presence of symptomatic problems associated with teeth, mouth opening, dry mouth (xerostomia), sticky saliva, coughing, and ill feeling [<xref rid="B9" ref-type="bibr">10</xref>]. Both the EORTC QLQ-C30 and QLQ-H&#x00026;N35 were scored according to the EORTC QLQ-C30 scoring manual [<xref rid="B9" ref-type="bibr">10</xref>]. In brief, all of the scale and item raw scores were linearly transformed into a 0 to 100 scale. A higher score represents a higher level of functioning on the QLQ-C30 functional scale or a higher level of global health status on the global health status/QOL scale. However, a higher score on the QLQ-C30/QLQ-H&#x00026;N35 symptom scale indicates more symptoms or problems, suggesting a greater impairment in QOL [<xref rid="B9" ref-type="bibr">10</xref>].</p></sec><sec id="sec2.4"><title>2.4. Statistical Analysis</title><p>The Kolmogorov-Smirnov test was used to check normality of all continuous data. Independent<italic> t</italic>-tests (for continuous variables) and chi-square tests (for categorical variables) were used to compare the demographic characteristics and all outcome variables of the Qigong and control groups before the training intervention began (baseline). Intention-to-treat analysis, specifically the last observation carried forward method, was employed to handle the missing data. To assess the time-by-group interaction effect of Qigong training on the global health status, two-way repeated measures analysis of covariance (ANCOVA) with mixed design (within-subject factor: time and between-subject factor: group) was used.</p><p>In addition, two-way repeated measures multivariate analysis of covariance (MANCOVA) was performed to evaluate the overall time-by-group interaction, group and time effects of Qigong training on (1) functional scale outcomes and (2) symptom scale outcomes of EORTC QLQ-C30 and QLQ-H&#x00026;N35. Multivariate tests were used instead of univariate tests to avoid an increase in type I error associated with multiple comparisons. If there were significant between-group differences in any outcome variables at baseline, these outstanding outcomes were treated as covariates in the multivariate and univariate tests mentioned above. Effect sizes (partial eta-squared) were also reported. By convention, values of 0.14, 0.06, and 0.01 represent large, medium, and small effects, respectively [<xref rid="B12" ref-type="bibr">13</xref>].</p><p>If the two-way repeated measures MANCOVA or ANCOVA revealed significant effects overall, follow-up analyses were performed using one-way repeated measures analysis of variance (ANOVA) and post hoc paired<italic> t</italic>-tests with Bonferroni correction as appropriate. Independent<italic> t</italic>-tests were also used to compare the outstanding outcome variables between the two groups. The significance level (alpha) was set at 0.05 (two-tailed) for all the tests except the paired<italic> t</italic>-tests (alpha was set at 0.008 due to six pairwise comparisons). All statistical analyses were performed using the IBM Statistical Package for the Social Sciences (SPSS) version 20.0 software (IBM, Armonk, NY, USA).</p></sec></sec><sec id="sec3"><title>3. Results</title><p>Fifty-two survivors of NPC were eligible to join the study and completed the baseline assessments. Twenty-five participants underwent Qigong training voluntarily for six months while twenty-seven participants acted as controls. At the end of the study, 14 participants in the experimental group had completed the Qigong training and the follow-up tests (i.e., dropout rate = 44.0%) and 21 participants in the control group had completed the follow-up tests (i.e., dropout rate = 22.2%). The reasons for dropping out were similar between the two groups. For the Qigong group, subjects who left the trial reported they were busy (<italic>n</italic> = 4), sick (<italic>n</italic> = 2), or unable to commit to the time (<italic>n</italic> = 5). Those control group subjects who stopped participating were busy (<italic>n</italic> = 1), unable to commit to the time (<italic>n</italic> = 1), overseas (<italic>n</italic> = 1), or unreachable (<italic>n</italic> = 3). No adverse effects were reported during the in-class Qigong training or the home practice. The Qigong class attendance rate was on average approximately 90%.</p><sec id="sec3.1"><title>3.1. Comparison of Baseline Data</title><p>No significant differences were found in any of the demographic (<xref ref-type="table" rid="tab2">Table 2</xref>) and outcome variables (<xref ref-type="table" rid="tab3">Table 3</xref>) between the two groups at baseline (<italic>P</italic> &#x0003e; 0.05). Therefore, analysis of variance (ANOVA) instead of ANCOVA was performed in all the univariate and multivariate tests.</p></sec><sec id="sec3.2"><title>3.2. Global Health Status/QOL</title><p>Two-way repeated measures ANOVA results revealed that the group &#x000d7; time interaction and group effects were not significant (<italic>P</italic> &#x0003e; 0.05). However, the time effect was significant (<italic>P</italic> = 0.011) (<xref ref-type="table" rid="tab3">Table 3</xref>). Post hoc paired <italic>t</italic>-tests showed that the global health status score, representing health-related QOL, was 12.6% higher at posttest (<italic>P</italic> = 0.001) and 15.9% higher at followup (<italic>P</italic> = 0.006) when compared to the pretest value of the control group. No significant differences (<italic>P</italic> &#x0003e; 0.05) were found in other pairwise comparisons between time points (<xref ref-type="table" rid="tab3">Table 3</xref>).</p></sec><sec id="sec3.3"><title>3.3. EORTC QLQ-C30 Functional Scale Outcomes</title><p>The <italic>P</italic> values and effect sizes of the multivariate analysis are presented in <xref ref-type="table" rid="tab3">Table 3</xref>. No significant group &#x000d7; time, group or time effects (<italic>P</italic> &#x0003e; 0.05) were found. Therefore follow-up univariate analyses were not performed.</p></sec><sec id="sec3.4"><title>3.4. EORTC QLQ-C30 Symptom Scale Outcomes</title><p>Similar to the QLQ-C30 functional scale outcomes, no significant group &#x000d7; time, group or time effects (<italic>P</italic> &#x0003e; 0.05) were found in the multivariate analysis (<xref ref-type="table" rid="tab3">Table 3</xref>).</p></sec><sec id="sec3.5"><title>3.5. EORTC QLQ-H&#x00026;N35 Symptom Scale Outcomes</title><p>MANOVA results showed that the group &#x000d7; time interaction and time effects were not significant (<italic>P</italic> &#x0003e; 0.05). Only the group effect was significant (<italic>P</italic> = 0.003). Follow-up independent<italic> t</italic>-tests identified significant between-group differences at (1) midintervention (<italic>P</italic> = 0.027), posttest (<italic>P</italic> = 0.017), and follow-up test (<italic>P</italic> = 0.006) for the sense problems outcome and (2) midintervention (<italic>P</italic> = 0.038) and posttest (<italic>P</italic> = 0.034) for the speech problems outcome (<xref ref-type="table" rid="tab3">Table 3</xref>). The control group had higher scores for sense-related (smell and taste) problems but lower speech-related problem scores than the Qigong group during and after the Qigong intervention (<xref ref-type="table" rid="tab3">Table 3</xref>).</p></sec></sec><sec id="sec4"><title>4. Discussion</title><p>This is the first study to assess the impact of Qigong training on QOL for cancer-free survivors of NPC. Our results show that Qigong training did not improve health-related QOL for the intervention group. Instead global health status/QOL improved in the no-training control group. Our findings are in contrast to previous studies and do not support our hypotheses. Qigong has been proposed to improve QOL in cancer patients [<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B13" ref-type="bibr">14</xref>] through several possible mechanisms, including reducing the side effects of conventional cancer treatments and cancer-related symptoms [<xref rid="B7" ref-type="bibr">7</xref>], decreasing inflammation [<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>], and increasing cognitive function [<xref rid="B8" ref-type="bibr">8</xref>]. A major reason for the discrepancy in findings between our study and the previous studies could be the difference in the participants' characteristics. Previous randomized controlled trials included heterogeneous cancer patients (e.g., breast cancer, lymphoma, and lung cancer) who had received/were receiving different forms of conventional cancer treatments. All of them were recruited from hospitals [<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>]. Newly diagnosed cancer patients and patients in the treatment stage could be more prone to anxiety, depression, and other psychological impairments than rehabilitated survivors of cancer [<xref rid="B14" ref-type="bibr">15</xref>]. Hence, they may benefit more from Qigong training in terms of improving QOL [<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>].</p><p>Our study included survivors of NPC exclusively. They were recruited from a medical clinic and a cancer self-help group. All of them were cancer-free during the study period. The post-NPC duration for the Qigong group was 12.5 years while for the control group it was 8.4 years. They may thus have fewer symptoms and functional impairments and so better health-related QOL overall when compared to hospitalized cancer patients. The mean global health status/QOL score of the Qigong group (61.8) actually exceeded the EORTC QLQ-C30 reference value (61.3) at pretest [<xref rid="B15" ref-type="bibr">16</xref>]. Thus, we postulate that Qigong training may not improve their relatively high level of QOL further. Instead, spontaneous improvement could heighten their health-related QOL, as demonstrated in the no-training control group. Further study should include a larger sample and adopt a randomized controlled study design to investigate this hypothesis. In addition, qualitative studies (e.g., structured interviews) could be carried out to discover the reasons for the spontaneous improvement in QOL among survivors of NPC.</p><p>The results also revealed that, over the study period, neither the Qigong group nor the control group showed significant improvements in physical, role, emotional, cognitive, or social functions. These findings are not entirely surprising given the fact that our participants had generally higher EORTC QLQ-C30 functional scores than the norm [<xref rid="B15" ref-type="bibr">16</xref>] at baseline. Perhaps no further improvements in functioning were possible regardless of the stimulus. This is the first study to include a group of rehabilitated survivors of NPC. Comparing our results with those obtained for cancer patients [<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>] may not be appropriate. Further randomized controlled trials should be carried out to explore whether or not Qigong training can further improve functions in survivors of NPC.</p><p>Among all of the general cancer symptoms (QLQ-C30 symptom scores) and NPC-specific symptoms (QLQ-H&#x00026;N35 symptom scores) measured, only the sense-related problems score was lower in the Qigong group than in the control group during and after the intervention period. The Qigong group continued to have fewer sense-related (smell and taste) problems than the control group up to six months after the cessation of training. Our findings are in line with a previous case report that suggested that smelling and taste in the mouth changed during Qigong practice [<xref rid="B16" ref-type="bibr">17</xref>]. These findings are encouraging because chronic smell and taste disorders are common among survivors of NPC [<xref rid="B17" ref-type="bibr">18</xref>, <xref rid="B18" ref-type="bibr">19</xref>]. These consequences of NPC and/or side effects of chemotherapy and radiotherapy can impair food intake and so may lead to nutritional deficits and diminished QOL [<xref rid="B17" ref-type="bibr">18</xref>, <xref rid="B19" ref-type="bibr">20</xref>, <xref rid="B20" ref-type="bibr">21</xref>]. However, no effective curative strategy has been developed [<xref rid="B17" ref-type="bibr">18</xref>, <xref rid="B21" ref-type="bibr">22</xref>, <xref rid="B22" ref-type="bibr">23</xref>].</p><p>Qigong has potential use as a remedial intervention to improve perceived taste and smell in survivors of NPC. During the NPC-targeted exercises of the Qigong intervention, participants were requested to massage their oral cavity with their tongue (<xref ref-type="table" rid="tab1">Table 1</xref>). We postulated that this technique might stimulate the taste buds, cortical representation of taste [<xref rid="B23" ref-type="bibr">24</xref>], and saliva production, which are essential for the taste sensation [<xref rid="B17" ref-type="bibr">18</xref>]. In addition, the olfactory stimulation exercises required the participants to breathe in slowly and deeply as if they were smelling a flower (<xref ref-type="table" rid="tab1">Table 1</xref>). This kind of exercise might stimulate the olfactory receptors located in the nasal cavity, which are crucial for smell and taste sensations [<xref rid="B17" ref-type="bibr">18</xref>]. Further study should evaluate smell and taste sensations objectively, for example, using the &#x0201c;Sniffin' Sticks&#x0201d; test [<xref rid="B18" ref-type="bibr">19</xref>], to exclude possible psychological or placebo effects before suggesting Qigong training for NPC survivors.</p><p>Another statistically significant finding is that the Qigong group experienced more speech problems than the control group at posttest and follow-up test. This finding was unanticipated as a previous study found that Qigong could improve speech fluency in people who stutter, as they gained more control over muscular tension after the exercise [<xref rid="B24" ref-type="bibr">25</xref>]. The speech-related problems considered in the QLQ-H&#x00026;N35 questionnaire concerned hoarseness and trouble talking to others [<xref rid="B9" ref-type="bibr">10</xref>], which may not be directly related to muscular control of sound production. Further study should explore whether the increased speech problems observed are due to Qigong training, aging, smell and taste problems, and so forth.</p><p>The Qigong training intervention was not able to alleviate symptoms such as fatigue, pain, insomnia, and swallowing problems in survivors of NPC (<xref ref-type="table" rid="tab3">Table 3</xref>). This may be because our participants had been fully rehabilitated and did not have residual cancer-related problems [<xref rid="B15" ref-type="bibr">16</xref>]. As a result, Qigong training might not be able to further lessen their symptoms.</p><p>This study has several limitations and findings should be interpreted with caution. First, the group assignment was non-randomized. Participants in the Qigong group may have been more motivated to seek treatments or training, and, therefore, they may have had fewer symptoms (e.g., sense-related problems) than the control group [<xref rid="B12" ref-type="bibr">13</xref>]. Second, due to the nature of the Qigong intervention, blinding of participants was not possible. In addition, we used self-report questionnaires to measure outcomes, so bias/placebo effects (e.g., participants perceive they feel better after Qigong training) cannot be excluded. Third, the sample size is rather small that may have compromised the statistical power leading to the insignificant results [<xref rid="B25" ref-type="bibr">26</xref>]. Finally, all of the participants were cancer-free survivors. The results cannot be generalized to patients of NPC who may have more symptoms and poorer functions. The effect of Qigong training on patients with NPC requires further investigation. Moreover, further study should take confounding factors (e.g., social support) into account when measuring QOL in survivors of NPC.</p></sec><sec id="sec5"><title>5. Conclusions</title><p>In summary, this clinical trial indicated that Qigong training confers no apparent improvement on health-related quality of life, functioning, or cancer-related symptoms in survivors of NPC. Further study is required to determine whether the improvement in taste- and smell-related problems perceived by survivors of NPC during and after Qigong training was due to actual recovery of senses or due to the placebo effect only.</p></sec></body><back><ack><title>Acknowledgments</title><p>This study was supported by a Seed Fund for Basic Research for New Staff (201308159012) from the University of Hong Kong and an Internal Research Grant (RG57/2012-2013R) from the Hong Kong Institute of Education. The authors would like to thank Professor L. Lam for providing advice on the use of questionnaires and Professor Rich Masters for his intellectual input, advice, and support.</p></ack><sec sec-type="conflict"><title>Conflict of Interests</title><p>The authors declare that they have no conflict of interests with respect to the authorship or publication of this paper.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Sarraf</surname><given-names>M</given-names></name><name><surname>Reddy</surname><given-names>MS</given-names></name></person-group><article-title>Nasopharyngeal carcinoma</article-title><source><italic>Current Treatment Options in Oncology</italic></source><year>2002</year><volume>3</volume><issue>1</issue><fpage>21</fpage><lpage>32</lpage><pub-id pub-id-type="other">2-s2.0-0036482034</pub-id><pub-id pub-id-type="pmid">12057084</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agulnik</surname><given-names>M</given-names></name><name><surname>Epstein</surname><given-names>JB</given-names></name></person-group><article-title>Nasopharyngeal carcinoma: current management, future directions and dental implications</article-title><source><italic>Oral Oncology</italic></source><year>2008</year><volume>44</volume><issue>7</issue><fpage>617</fpage><lpage>627</lpage><pub-id pub-id-type="other">2-s2.0-45449090278</pub-id><pub-id pub-id-type="pmid">18061518</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>F-M</given-names></name><name><surname>Chiu</surname><given-names>H-C</given-names></name><name><surname>Kuo</surname><given-names>W-R</given-names></name><etal/></person-group><article-title>Health-related quality of life for nasopharyngeal carcinoma patients with cancer-free survival after treatment</article-title><source><italic>International Journal of Radiation Oncology, Biology, Physics</italic></source><year>2002</year><volume>53</volume><issue>4</issue><fpage>959</fpage><lpage>968</lpage><pub-id pub-id-type="other">2-s2.0-0037100036</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cengiz</surname><given-names>M</given-names></name><name><surname>Ozyar</surname><given-names>E</given-names></name><name><surname>Esassolak</surname><given-names>M</given-names></name><etal/></person-group><article-title>Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&#x00026;N-35 modules</article-title><source><italic>International Journal of Radiation Oncology, Biology, Physics</italic></source><year>2005</year><volume>63</volume><issue>5</issue><fpage>1347</fpage><lpage>1353</lpage><pub-id pub-id-type="other">2-s2.0-27744513810</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mak</surname><given-names>YK</given-names></name></person-group><source><italic>18 Forms Tai Chi Qigong</italic></source><edition>7th edition</edition><publisher-loc>Hong Kong, China</publisher-loc><publisher-name>Wan Li Book Co</publisher-name><comment>(Chinese)</comment></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fong</surname><given-names>SSM</given-names></name><name><surname>Ng</surname><given-names>SSM</given-names></name><name><surname>Luk</surname><given-names>WS</given-names></name><etal/></person-group><article-title>Shoulder mobility, muscular strength, and quality of life in breast cancer survivors with and without Tai Chi Qigong training</article-title><source><italic>Evidence-Based Complementary and Alternative Medicine</italic></source><year>2013</year><volume>2013</volume><fpage>6 pages</fpage><pub-id pub-id-type="other">2-s2.0-84877986268</pub-id><pub-id pub-id-type="publisher-id">787169</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>B</given-names></name><name><surname>Butow</surname><given-names>P</given-names></name><name><surname>Mullan</surname><given-names>B</given-names></name><name><surname>Clarke</surname><given-names>S</given-names></name></person-group><article-title>Medical Qigong for cancer patients: pilot study of impact on quality of life, side effects of treatment and inflammation</article-title><source><italic>The American Journal of Chinese Medicine</italic></source><year>2008</year><volume>36</volume><issue>3</issue><fpage>459</fpage><lpage>472</lpage><pub-id pub-id-type="other">2-s2.0-44949092633</pub-id><pub-id pub-id-type="pmid">18543381</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>B</given-names></name><name><surname>Butow</surname><given-names>PN</given-names></name><name><surname>Mullan</surname><given-names>BA</given-names></name><etal/></person-group><article-title>Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial</article-title><source><italic>Supportive Care in Cancer</italic></source><year>2012</year><volume>20</volume><issue>6</issue><fpage>1235</fpage><lpage>1242</lpage><pub-id pub-id-type="other">2-s2.0-84863981571</pub-id><pub-id pub-id-type="pmid">21688163</pub-id></element-citation></ref><ref id="B26"><label>9</label><element-citation publication-type="book"><collab>American Joint Committee on Cancer</collab><source><italic>AJCC Cancer Staging Manual</italic></source><year>1997</year><edition>5th edition</edition><publisher-loc>Philadelphia, Pa, USA</publisher-loc><publisher-name>Lippincott Williams &#x00026; Wilkins</publisher-name></element-citation></ref><ref id="B9"><label>10</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fayers</surname><given-names>PM</given-names></name><name><surname>Aaronson</surname><given-names>NK</given-names></name><name><surname>Bjordal</surname><given-names>K</given-names></name><name><surname>Groenvold</surname><given-names>M</given-names></name><name><surname>Curran</surname><given-names>D</given-names></name><name><surname>Bottomley</surname><given-names>A</given-names></name></person-group><source><italic>The EORTC QLQ-C30 Scoring Manual</italic></source><year>2001</year><edition>3rd edition</edition><publisher-loc>Brussels, Belgium</publisher-loc><publisher-name>European Organisation for Research and Treatment of Cancer</publisher-name></element-citation></ref><ref id="B10"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Kanda</surname><given-names>K</given-names></name></person-group><article-title>Translation and validation of the standard Chinese version of the EORTC QLQ-C30</article-title><source><italic>Quality of Life Research</italic></source><year>2000</year><volume>9</volume><issue>2</issue><fpage>129</fpage><lpage>137</lpage><pub-id pub-id-type="other">2-s2.0-0033863434</pub-id><pub-id pub-id-type="pmid">10983477</pub-id></element-citation></ref><ref id="B11"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Kanda</surname><given-names>K</given-names></name></person-group><article-title>Testing psychometric properties of the standard Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30)</article-title><source><italic>Journal of Epidemiology</italic></source><year>2004</year><volume>14</volume><issue>6</issue><fpage>193</fpage><lpage>203</lpage><pub-id pub-id-type="other">2-s2.0-16644403743</pub-id><pub-id pub-id-type="pmid">15617393</pub-id></element-citation></ref><ref id="B12"><label>13</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Portney</surname><given-names>LG</given-names></name><name><surname>Watkins</surname><given-names>MP</given-names></name></person-group><source><italic>Foundations of Clinical Research: Applications to Practice</italic></source><year>2009</year><edition>3rd edition</edition><publisher-loc>Upper Saddle River, NJ, USA</publisher-loc><publisher-name>Pearson Education</publisher-name></element-citation></ref><ref id="B13"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>T</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Cheng</surname><given-names>ASK</given-names></name></person-group><article-title>Health benefits of Qigong or Tai Chi for cancer patients: a systematic review and meta-analyses</article-title><source><italic>Complementary Therapies in Medicine</italic></source><year>2014</year><volume>22</volume><issue>1</issue><fpage>173</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">24559833</pub-id></element-citation></ref><ref id="B14"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>A</given-names></name><name><surname>Lauche</surname><given-names>R</given-names></name><name><surname>Cramer</surname><given-names>H</given-names></name><name><surname>Altner</surname><given-names>N</given-names></name><name><surname>Langhorst</surname><given-names>J</given-names></name><name><surname>Dobos</surname><given-names>GJ</given-names></name></person-group><article-title>An oncology mind-body medicine day care clinic: concept and case presentation</article-title><source><italic>Integrative Cancer Therapies</italic></source><year>2013</year><volume>12</volume><issue>6</issue><fpage>503</fpage><lpage>507</lpage><pub-id pub-id-type="pmid">23329568</pub-id></element-citation></ref><ref id="B15"><label>16</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>NW</given-names></name><name><surname>Fayers</surname><given-names>PM</given-names></name><name><surname>Aaronson</surname><given-names>NK</given-names></name><etal/></person-group><source><italic>EORTC QLQ-C30 Reference Values</italic></source><year>2008</year><publisher-loc>Brussels, Belgium</publisher-loc><publisher-name>European Organisation for Research and Treatment of Cancer</publisher-name></element-citation></ref><ref id="B16"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jouper</surname><given-names>J</given-names></name><name><surname>Johansson</surname><given-names>M</given-names></name></person-group><article-title>Qigong and mindfulness-based mood recovery: exercise experiences from a single case</article-title><source><italic>Journal of Bodywork and Movement Therapies</italic></source><year>2013</year><volume>17</volume><issue>1</issue><fpage>69</fpage><lpage>76</lpage><pub-id pub-id-type="other">2-s2.0-84872010997</pub-id><pub-id pub-id-type="pmid">23294686</pub-id></element-citation></ref><ref id="B17"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravasco</surname><given-names>P</given-names></name></person-group><article-title>Aspects of taste and compliance in patients with cancer</article-title><source><italic>European Journal of Oncology Nursing</italic></source><year>2005</year><volume>9</volume><issue>supplement 2</issue><fpage>S84</fpage><lpage>S91</lpage><pub-id pub-id-type="other">2-s2.0-27144526119</pub-id><pub-id pub-id-type="pmid">16437761</pub-id></element-citation></ref><ref id="B18"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>W-K</given-names></name><name><surname>Kwong</surname><given-names>DLW</given-names></name><name><surname>Wei</surname><given-names>WI</given-names></name><name><surname>Sham</surname><given-names>JST</given-names></name></person-group><article-title>Change in olfaction after radiotherapy for nasopharyngeal cancer&#x02014;a prospective study</article-title><source><italic>American Journal of Otolaryngology: Head and Neck Medicine and Surgery</italic></source><year>2002</year><volume>23</volume><issue>4</issue><fpage>209</fpage><lpage>214</lpage><pub-id pub-id-type="other">2-s2.0-0036303542</pub-id></element-citation></ref><ref id="B19"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epstein</surname><given-names>JB</given-names></name><name><surname>Barasch</surname><given-names>A</given-names></name></person-group><article-title>Taste disorders in cancer patients: pathogenesis, and approach to assessment and management</article-title><source><italic>Oral Oncology</italic></source><year>2010</year><volume>46</volume><issue>2</issue><fpage>77</fpage><lpage>81</lpage><pub-id pub-id-type="other">2-s2.0-74649083950</pub-id><pub-id pub-id-type="pmid">20036797</pub-id></element-citation></ref><ref id="B20"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comeau</surname><given-names>TB</given-names></name><name><surname>Epstein</surname><given-names>JB</given-names></name><name><surname>Migas</surname><given-names>C</given-names></name></person-group><article-title>Taste and smell dysfunction in patients receiving chemotherapy: a review of current knowledge</article-title><source><italic>Supportive Care in Cancer</italic></source><year>2001</year><volume>9</volume><issue>8</issue><fpage>575</fpage><lpage>580</lpage><pub-id pub-id-type="other">2-s2.0-0035165032</pub-id><pub-id pub-id-type="pmid">11762967</pub-id></element-citation></ref><ref id="B21"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiffman</surname><given-names>SS</given-names></name><name><surname>Gatlin</surname><given-names>CA</given-names></name></person-group><article-title>Clinical physiology of taste and smell</article-title><source><italic>Annual Review of Nutrition</italic></source><year>1993</year><volume>13</volume><fpage>405</fpage><lpage>436</lpage><pub-id pub-id-type="other">2-s2.0-0027294033</pub-id></element-citation></ref><ref id="B22"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rehwaldt</surname><given-names>M</given-names></name><name><surname>Wickham</surname><given-names>R</given-names></name><name><surname>Purl</surname><given-names>S</given-names></name><etal/></person-group><article-title>Self-care strategies to cope with taste changes after chemotherapy</article-title><source><italic>Oncology Nursing Forum</italic></source><year>2009</year><volume>36</volume><issue>2</issue><fpage>E47</fpage><lpage>E56</lpage><pub-id pub-id-type="other">2-s2.0-67649214100</pub-id><pub-id pub-id-type="pmid">19273394</pub-id></element-citation></ref><ref id="B23"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bornstein</surname><given-names>WS</given-names></name></person-group><article-title>Cortical representation of taste in man and monkey II. The localization of the cortical taste area in man and a method of measuring impairment of taste in man</article-title><source><italic>Yale Journal of Biology and Medicine</italic></source><year>1940</year><volume>13</volume><issue>1</issue><fpage>133</fpage><lpage>156</lpage><pub-id pub-id-type="pmid">21433927</pub-id></element-citation></ref><ref id="B24"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potrola</surname><given-names>P</given-names></name><name><surname>Goral-Potrola</surname><given-names>J</given-names></name></person-group><article-title>In search of new methods. Qigong in stuttering therapy</article-title><source><italic>Studia Medyczne</italic></source><year>2013</year><volume>29</volume><issue>3</issue><fpage>242</fpage><lpage>250</lpage></element-citation></ref><ref id="B25"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>MT</given-names></name><name><surname>Bell</surname><given-names>ML</given-names></name><name><surname>Costa</surname><given-names>D</given-names></name><name><surname>Butow</surname><given-names>P</given-names></name><name><surname>Oh</surname><given-names>B</given-names></name></person-group><article-title>The Quality of Life Questionnaire Core 30 (QLQ-C30) and Functional Assessment of Cancer-General (FACT-G) differ in responsiveness, relative efficiency, and therefore required sample size</article-title><source><italic>Journal of Clinical Epidemiology</italic></source><year>2014</year><volume>67</volume><issue>1</issue><fpage>100</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">24125895</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Qigong exercise protocol.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Exercise type</th><th align="center" rowspan="1" colspan="1">Duration</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Warm-up: jogging </td><td align="center" rowspan="1" colspan="1">5 minutes</td></tr><tr><td align="left" rowspan="1" colspan="1">18 Forms Tai Chi Internal Qigong [<xref rid="B5" ref-type="bibr">5</xref>]</td><td align="center" rowspan="1" colspan="1">40 minutes</td></tr><tr><td align="left" rowspan="1" colspan="1">(1) Raising the arms and pressing down</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(2) Opening the chest</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(3) Painting a rainbow from side to side</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(4) Separating the clouds with two arms</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(5) Rolling the arms in a horse-riding stance</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(6) Rowing the boat</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(7) Carrying a ball in front of the shoulders</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(8) Turning around to look at the moon</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(9) Twisting the waist and pushing the palms</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(10) Cloud hands in a horse-riding stance</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(11) Scooping the sea and searching the sky</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(12) Pushing waves in walking stance</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(13) Flying dove spreads its wings</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(14) Punching in horse stance</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(15) Flying like wild geese</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(16) Rotating a flying wheel</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(17) Stepping whilst bouncing a ball</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(18) Pressing down to balance the chi</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">Additional NPC-targeted exercises</td><td align="center" rowspan="1" colspan="1">40 minutes</td></tr><tr><td align="left" rowspan="1" colspan="1">(1) Arms cross in front and curl up the body </td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(2) Place hands behind the neck</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(3) Olfactory stimulation (e.g., breathe in slowly <break/>&#x02003; and deeply, imagine smelling a flower)</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(4) Inner ear stimulation (e.g., different head and neck <break/>&#x02003; movements)</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(5) Oral and swallowing exercise (e.g., use the tip of the <break/>&#x02003; tongue to massage the maxilla and swallow <break/>&#x02003; saliva bit by bit)</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">(6) Mouth-opening exercise and make sounds with <break/>&#x02003; the throat</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">Cooldown: gentle whole-body stretching </td><td align="center" rowspan="1" colspan="1">5 minutes</td></tr></tbody></table></table-wrap><table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Characteristics of participants measured at baseline.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">&#x02009;</th><th align="center" rowspan="1" colspan="1">Qigong group <break/>(<italic>n</italic> = 25)</th><th align="center" rowspan="1" colspan="1">Control group <break/>(<italic>n</italic> = 27)</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (year)</td><td align="center" rowspan="1" colspan="1">55.4 &#x000b1; 7.5</td><td align="center" rowspan="1" colspan="1">58.7 &#x000b1; 9.5</td><td align="center" rowspan="1" colspan="1">0.172</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex (number of male&#x02009;:&#x02009;female)</td><td align="center" rowspan="1" colspan="1">12&#x02009;:&#x02009;13</td><td align="center" rowspan="1" colspan="1">16&#x02009;:&#x02009;11</td><td align="center" rowspan="1" colspan="1">0.416</td></tr><tr><td align="left" rowspan="1" colspan="1">Weight (kg)</td><td align="center" rowspan="1" colspan="1">59.5 &#x000b1; 15.1</td><td align="center" rowspan="1" colspan="1">56.8 &#x000b1; 10.5</td><td align="center" rowspan="1" colspan="1">0.451</td></tr><tr><td align="left" rowspan="1" colspan="1">Height (cm)</td><td align="center" rowspan="1" colspan="1">163.2 &#x000b1; 9.1</td><td align="center" rowspan="1" colspan="1">161.5 &#x000b1; 8.1</td><td align="center" rowspan="1" colspan="1">0.496</td></tr><tr><td align="left" rowspan="1" colspan="1">Body mass index (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">22.3 &#x000b1; 5.0</td><td align="center" rowspan="1" colspan="1">21.7 &#x000b1; 3.3</td><td align="center" rowspan="1" colspan="1">0.640</td></tr><tr><td align="left" rowspan="1" colspan="1">Reported NPC stage at diagnosis [<xref rid="B26" ref-type="bibr">9</xref>]</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Stage I (<italic>n</italic>, %)</td><td align="center" rowspan="1" colspan="1">5 (20%)</td><td align="center" rowspan="1" colspan="1">2 (7.4%)</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Stage II (<italic>n</italic>, %)</td><td align="center" rowspan="1" colspan="1">5 (20%)</td><td align="center" rowspan="1" colspan="1">7 (25.9%)</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Stage III (<italic>n</italic>, %)</td><td align="center" rowspan="1" colspan="1">11 (44%)</td><td align="center" rowspan="1" colspan="1">15 (55.6%)</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Stage IV (<italic>n</italic>, %)</td><td align="center" rowspan="1" colspan="1">4 (16%)</td><td align="center" rowspan="1" colspan="1">3 (11.1%)</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">Post-NPC duration (year)</td><td align="center" rowspan="1" colspan="1">12.5 &#x000b1; 7.1</td><td align="center" rowspan="1" colspan="1">8.4 &#x000b1; 9.7</td><td align="center" rowspan="1" colspan="1">0.094</td></tr><tr><td align="left" rowspan="1" colspan="1">Previous NPC treatment</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Radiotherapy (<italic>n</italic>, %)</td><td align="center" rowspan="1" colspan="1">17 (68%)</td><td align="center" rowspan="1" colspan="1">9 (33.3%)</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Radiotherapy and <break/>&#x02003;chemotherapy (<italic>n</italic>, %)</td><td align="center" rowspan="1" colspan="1">7 (28%)</td><td align="center" rowspan="1" colspan="1">18 (66.6%)</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Radiotherapy, <break/>&#x02003;chemotherapy, and <break/>&#x02003;surgery (<italic>n</italic>, %)</td><td align="center" rowspan="1" colspan="1">1 (4%)</td><td align="center" rowspan="1" colspan="1">0 (0%)</td><td align="center" rowspan="1" colspan="1">&#x02009;</td></tr><tr><td align="left" rowspan="1" colspan="1">Habitual physical activity level (metabolic equivalent hours per week)</td><td align="center" rowspan="1" colspan="1">13.9 &#x000b1; 14.1</td><td align="center" rowspan="1" colspan="1">14.9 &#x000b1; 14.5</td><td align="center" rowspan="1" colspan="1">0.795</td></tr></tbody></table><table-wrap-foot><fn><p>Mean &#x000b1; standard deviation presented for continuous variables.</p></fn><fn><p>*<italic>P</italic> &#x0003c; 0.05 for between-group comparisons.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab3" orientation="portrait" position="float"><label>Table 3</label><caption><p>EORTC scores measured at four time points.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">&#x02009;</th><th align="center" colspan="4" rowspan="1">Qigong group (<italic>n</italic> = 25)</th><th align="center" colspan="4" rowspan="1">Control group (<italic>n</italic> = 27)</th><th align="center" colspan="2" rowspan="1">
Group &#x000d7; time interaction</th><th align="center" colspan="2" rowspan="1">
Group effect</th><th align="center" colspan="2" rowspan="1">
Time effect</th></tr><tr><th align="left" rowspan="1" colspan="1">&#x02009;</th><th align="center" rowspan="1" colspan="1">Pre </th><th align="center" rowspan="1" colspan="1">Mid</th><th align="center" rowspan="1" colspan="1">Post </th><th align="center" rowspan="1" colspan="1">FU </th><th align="center" rowspan="1" colspan="1">Pre </th><th align="center" rowspan="1" colspan="1">Mid</th><th align="center" rowspan="1" colspan="1">Post </th><th align="center" rowspan="1" colspan="1">FU </th><th align="center" rowspan="1" colspan="1">Effect size</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic>
</th><th align="center" rowspan="1" colspan="1">Effect size</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic>
</th><th align="center" rowspan="1" colspan="1">Effect size</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic>
</th></tr></thead><tbody><tr><td align="left" colspan="15" rowspan="1">EORTC QLQ-C30 </td></tr><tr><td align="left" rowspan="1" colspan="1">Global health status/QOL</td><td align="center" rowspan="1" colspan="1">61.81 &#x000b1; 22.10</td><td align="center" rowspan="1" colspan="1">63.19 &#x000b1; 24.32</td><td align="center" rowspan="1" colspan="1">61.81 &#x000b1; 26.57</td><td align="center" rowspan="1" colspan="1">66.67 &#x000b1; 27.47</td><td align="center" rowspan="1" colspan="1">58.65 &#x000b1; 21.01</td><td align="center" rowspan="1" colspan="1">62.50 &#x000b1; 18.30</td><td align="center" rowspan="1" colspan="1">66.03 &#x000b1; 18.55<sup>a</sup>
</td><td align="center" rowspan="1" colspan="1">67.95 &#x000b1; 16.45<sup>a</sup>
</td><td align="center" rowspan="1" colspan="1">0.143</td><td align="center" rowspan="1" colspan="1">0.067</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">0.945</td><td align="center" rowspan="1" colspan="1">0.213</td><td align="center" rowspan="1" colspan="1">0.011*</td></tr><tr><td align="left" rowspan="1" colspan="1">Functional scales (higher scores = higher functions)</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">0.387</td><td align="center" rowspan="1" colspan="1">0.189</td><td align="center" rowspan="1" colspan="1">0.143</td><td align="center" rowspan="1" colspan="1">0.221</td><td align="center" rowspan="1" colspan="1">0.410</td><td align="center" rowspan="1" colspan="1">0.134</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Physical functioning</td><td align="center" rowspan="1" colspan="1">78.06 &#x000b1; 16.85</td><td align="center" rowspan="1" colspan="1">80.56 &#x000b1; 15.22</td><td align="center" rowspan="1" colspan="1">79.17 &#x000b1; 13.94</td><td align="center" rowspan="1" colspan="1">78.89 &#x000b1; 15.06</td><td align="center" rowspan="1" colspan="1">76.67 &#x000b1; 13.10</td><td align="center" rowspan="1" colspan="1">78.72 &#x000b1; 12.22</td><td align="center" rowspan="1" colspan="1">77.18 &#x000b1; 12.53</td><td align="center" rowspan="1" colspan="1">77.44 &#x000b1; 13.21</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Role functioning</td><td align="center" rowspan="1" colspan="1">80.56 &#x000b1; 22.88</td><td align="center" rowspan="1" colspan="1">81.25 &#x000b1; 21.03</td><td align="center" rowspan="1" colspan="1">84.03 &#x000b1; 21.69</td><td align="center" rowspan="1" colspan="1">86.11 &#x000b1; 21.80</td><td align="center" rowspan="1" colspan="1">87.18 &#x000b1; 19.04</td><td align="center" rowspan="1" colspan="1">86.54 &#x000b1; 18.27</td><td align="center" rowspan="1" colspan="1">85.90 &#x000b1; 18.07</td><td align="center" rowspan="1" colspan="1">84.62 &#x000b1; 21.56</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Emotional <break/>&#x02003;functioning</td><td align="center" rowspan="1" colspan="1">76.74 &#x000b1; 19.19</td><td align="center" rowspan="1" colspan="1">79.51 &#x000b1; 19.35</td><td align="center" rowspan="1" colspan="1">78.13 &#x000b1; 20.24</td><td align="center" rowspan="1" colspan="1">81.60 &#x000b1; 18.39</td><td align="center" rowspan="1" colspan="1">77.24 &#x000b1; 20.35</td><td align="center" rowspan="1" colspan="1">76.28 &#x000b1; 18.96</td><td align="center" rowspan="1" colspan="1">78.53 &#x000b1; 19.32</td><td align="center" rowspan="1" colspan="1">80.45 &#x000b1; 18.40</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Cognitive <break/>&#x02003;functioning</td><td align="center" rowspan="1" colspan="1">65.97 &#x000b1; 23.30</td><td align="center" rowspan="1" colspan="1">65.28 &#x000b1; 20.21</td><td align="center" rowspan="1" colspan="1">68.75 &#x000b1; 24.23</td><td align="center" rowspan="1" colspan="1">69.44 &#x000b1; 21.23</td><td align="center" rowspan="1" colspan="1">69.23 &#x000b1; 24.81</td><td align="center" rowspan="1" colspan="1">67.95 &#x000b1; 26.63</td><td align="center" rowspan="1" colspan="1">72.44 &#x000b1; 22.58</td><td align="center" rowspan="1" colspan="1">69.87 &#x000b1; 24.50</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Social functioning</td><td align="center" rowspan="1" colspan="1">74.31 &#x000b1; 25.53</td><td align="center" rowspan="1" colspan="1">75.69 &#x000b1; 26.00</td><td align="center" rowspan="1" colspan="1">77.08 &#x000b1; 27.72</td><td align="center" rowspan="1" colspan="1">79.86 &#x000b1; 26.46</td><td align="center" rowspan="1" colspan="1">86.54 &#x000b1; 18.87</td><td align="center" rowspan="1" colspan="1">87.18 &#x000b1; 17.20</td><td align="center" rowspan="1" colspan="1">85.90 &#x000b1; 16.12</td><td align="center" rowspan="1" colspan="1">83.33 &#x000b1; 17.00</td></tr><tr><td align="left" rowspan="1" colspan="1">Symptom scales (higher scores = more symptoms)</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">0.667</td><td align="center" rowspan="1" colspan="1">0.123</td><td align="center" rowspan="1" colspan="1">0.190</td><td align="center" rowspan="1" colspan="1">0.425</td><td align="center" rowspan="1" colspan="1">0.659</td><td align="center" rowspan="1" colspan="1">0.140</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Fatigue</td><td align="center" rowspan="1" colspan="1">37.50 &#x000b1; 20.67</td><td align="center" rowspan="1" colspan="1">36.11 &#x000b1; 18.89</td><td align="center" rowspan="1" colspan="1">34.72 &#x000b1; 20.54</td><td align="center" rowspan="1" colspan="1">33.80 &#x000b1; 21.85</td><td align="center" rowspan="1" colspan="1">35.47 &#x000b1; 18.06</td><td align="center" rowspan="1" colspan="1">34.19 &#x000b1; 17.76</td><td align="center" rowspan="1" colspan="1">38.03 &#x000b1; 17.26</td><td align="center" rowspan="1" colspan="1">35.47 &#x000b1; 19.88</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Nausea and vomiting</td><td align="center" rowspan="1" colspan="1">6.94 &#x000b1; 12.93</td><td align="center" rowspan="1" colspan="1">5.56 &#x000b1; 11.70</td><td align="center" rowspan="1" colspan="1">4.17 &#x000b1; 10.13</td><td align="center" rowspan="1" colspan="1">4.17 &#x000b1; 10.13</td><td align="center" rowspan="1" colspan="1">5.13 &#x000b1; 11.32</td><td align="center" rowspan="1" colspan="1">5.13 &#x000b1; 11.32</td><td align="center" rowspan="1" colspan="1">5.13 &#x000b1; 11.32</td><td align="center" rowspan="1" colspan="1">5.77 &#x000b1; 11.49</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Pain</td><td align="center" rowspan="1" colspan="1">32.64 &#x000b1; 24.81</td><td align="center" rowspan="1" colspan="1">31.94 &#x000b1; 23.01</td><td align="center" rowspan="1" colspan="1">29.86 &#x000b1; 24.07</td><td align="center" rowspan="1" colspan="1">25.69 &#x000b1; 24.56</td><td align="center" rowspan="1" colspan="1">25.64 &#x000b1; 20.13</td><td align="center" rowspan="1" colspan="1">24.36 &#x000b1; 19.57</td><td align="center" rowspan="1" colspan="1">26.92 &#x000b1; 18.90</td><td align="center" rowspan="1" colspan="1">27.56 &#x000b1; 18.82</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Dyspnea</td><td align="center" rowspan="1" colspan="1">31.94 &#x000b1; 25.02</td><td align="center" rowspan="1" colspan="1">29.17 &#x000b1; 20.41</td><td align="center" rowspan="1" colspan="1">23.61 &#x000b1; 20.80</td><td align="center" rowspan="1" colspan="1">23.61 &#x000b1; 20.80</td><td align="center" rowspan="1" colspan="1">26.92 &#x000b1; 24.98</td><td align="center" rowspan="1" colspan="1">23.08 &#x000b1; 20.59</td><td align="center" rowspan="1" colspan="1">24.36 &#x000b1; 22.23</td><td align="center" rowspan="1" colspan="1">25.64 &#x000b1; 21.72</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Insomnia</td><td align="center" rowspan="1" colspan="1">29.17 &#x000b1; 22.66</td><td align="center" rowspan="1" colspan="1">27.78 &#x000b1; 27.22</td><td align="center" rowspan="1" colspan="1">26.39 &#x000b1; 25.97</td><td align="center" rowspan="1" colspan="1">20.83 &#x000b1; 21.56</td><td align="center" rowspan="1" colspan="1">34.62 &#x000b1; 30.52</td><td align="center" rowspan="1" colspan="1">33.33 &#x000b1; 31.27</td><td align="center" rowspan="1" colspan="1">43.59 &#x000b1; 32.34</td><td align="center" rowspan="1" colspan="1">42.31 &#x000b1; 34.71</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Appetite loss</td><td align="center" rowspan="1" colspan="1">25.00 &#x000b1; 28.23</td><td align="center" rowspan="1" colspan="1">22.22 &#x000b1; 28.94</td><td align="center" rowspan="1" colspan="1">18.06 &#x000b1; 25.97</td><td align="center" rowspan="1" colspan="1">15.28 &#x000b1; 25.97</td><td align="center" rowspan="1" colspan="1">12.82 &#x000b1; 19.04</td><td align="center" rowspan="1" colspan="1">14.10 &#x000b1; 21.44</td><td align="center" rowspan="1" colspan="1">15.38 &#x000b1; 23.53</td><td align="center" rowspan="1" colspan="1">12.82 &#x000b1; 23.24</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Constipation</td><td align="center" rowspan="1" colspan="1">15.28 &#x000b1; 21.93</td><td align="center" rowspan="1" colspan="1">20.83 &#x000b1; 23.70</td><td align="center" rowspan="1" colspan="1">19.44 &#x000b1; 27.66</td><td align="center" rowspan="1" colspan="1">15.28 &#x000b1; 24.04</td><td align="center" rowspan="1" colspan="1">21.79 &#x000b1; 22.98</td><td align="center" rowspan="1" colspan="1">17.95 &#x000b1; 19.39</td><td align="center" rowspan="1" colspan="1">17.95 &#x000b1; 21.56</td><td align="center" rowspan="1" colspan="1">14.10 &#x000b1; 19.26</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Diarrhea</td><td align="center" rowspan="1" colspan="1">15.28 &#x000b1; 19.61</td><td align="center" rowspan="1" colspan="1">8.33 &#x000b1; 14.74</td><td align="center" rowspan="1" colspan="1">9.72 &#x000b1; 18.33</td><td align="center" rowspan="1" colspan="1">12.50 &#x000b1; 19.19</td><td align="center" rowspan="1" colspan="1">12.82 &#x000b1; 19.04</td><td align="center" rowspan="1" colspan="1">14.10 &#x000b1; 19.26</td><td align="center" rowspan="1" colspan="1">14.10 &#x000b1; 21.44</td><td align="center" rowspan="1" colspan="1">11.54 &#x000b1; 18.72</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Financial difficulties</td><td align="center" rowspan="1" colspan="1">26.39 &#x000b1; 31.05</td><td align="center" rowspan="1" colspan="1">26.39 &#x000b1; 32.57</td><td align="center" rowspan="1" colspan="1">20.83 &#x000b1; 33.78</td><td align="center" rowspan="1" colspan="1">19.44 &#x000b1; 32.48</td><td align="center" rowspan="1" colspan="1">12.82 &#x000b1; 19.04</td><td align="center" rowspan="1" colspan="1">14.10 &#x000b1; 19.26</td><td align="center" rowspan="1" colspan="1">15.38 &#x000b1; 16.95</td><td align="center" rowspan="1" colspan="1">17.95 &#x000b1; 19.39</td></tr><tr><td align="left" colspan="15" rowspan="1">
<hr/>
</td></tr><tr><td align="left" colspan="15" rowspan="1">EORTC QLQ-H&#x00026;N35</td></tr><tr><td align="left" rowspan="1" colspan="1">Symptom scales (higher scores = more symptoms)</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">&#x02009;</td><td align="center" rowspan="1" colspan="1">0.804</td><td align="center" rowspan="1" colspan="1">0.317</td><td align="center" rowspan="1" colspan="1">0.572</td><td align="center" rowspan="1" colspan="1">0.003*</td><td align="center" rowspan="1" colspan="1">0.804</td><td align="center" rowspan="1" colspan="1">0.317</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Pain</td><td align="center" rowspan="1" colspan="1">12.68 &#x000b1; 13.02</td><td align="center" rowspan="1" colspan="1">12.68 &#x000b1; 13.73</td><td align="center" rowspan="1" colspan="1">14.13 &#x000b1; 16.94</td><td align="center" rowspan="1" colspan="1">10.87 &#x000b1; 12.67</td><td align="center" rowspan="1" colspan="1">17.75 &#x000b1; 24.27</td><td align="center" rowspan="1" colspan="1">19.20 &#x000b1; 17.84</td><td align="center" rowspan="1" colspan="1">19.20 &#x000b1; 16.56</td><td align="center" rowspan="1" colspan="1">18.48 &#x000b1; 16.47</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Swallowing</td><td align="center" rowspan="1" colspan="1">34.03 &#x000b1; 25.05</td><td align="center" rowspan="1" colspan="1">31.94 &#x000b1; 26.66</td><td align="center" rowspan="1" colspan="1">34.38 &#x000b1; 25.81</td><td align="center" rowspan="1" colspan="1">34.72 &#x000b1; 24.90</td><td align="center" rowspan="1" colspan="1">29.32 &#x000b1; 18.69</td><td align="center" rowspan="1" colspan="1">28.70 &#x000b1; 17.95</td><td align="center" rowspan="1" colspan="1">28.09 &#x000b1; 17.01</td><td align="center" rowspan="1" colspan="1">26.23 &#x000b1; 16.13</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Sense problems</td><td align="center" rowspan="1" colspan="1">22.22 &#x000b1; 18.82</td><td align="center" rowspan="1" colspan="1">21.53 &#x000b1; 17.36<sup>b</sup>
</td><td align="center" rowspan="1" colspan="1">18.75 &#x000b1; 17.93<sup>b</sup>
</td><td align="center" rowspan="1" colspan="1">16.67 &#x000b1; 14.74<sup>b</sup>
</td><td align="center" rowspan="1" colspan="1">33.95 &#x000b1; 28.67</td><td align="center" rowspan="1" colspan="1">35.80 &#x000b1; 26.03</td><td align="center" rowspan="1" colspan="1">34.57 &#x000b1; 26.52</td><td align="center" rowspan="1" colspan="1">33.95 &#x000b1; 25.94</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Speech problems</td><td align="center" rowspan="1" colspan="1">29.17 &#x000b1; 24.91</td><td align="center" rowspan="1" colspan="1">28.24 &#x000b1; 25.38<sup>b</sup>
</td><td align="center" rowspan="1" colspan="1">27.78 &#x000b1; 25.80<sup>b</sup>
</td><td align="center" rowspan="1" colspan="1">23.61 &#x000b1; 23.47</td><td align="center" rowspan="1" colspan="1">18.52 &#x000b1; 22.85</td><td align="center" rowspan="1" colspan="1">14.81 &#x000b1; 19.49</td><td align="center" rowspan="1" colspan="1">13.99 &#x000b1; 19.14</td><td align="center" rowspan="1" colspan="1">12.76 &#x000b1; 18.92</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Trouble with social <break/>&#x02003;eating</td><td align="center" rowspan="1" colspan="1">39.24 &#x000b1; 32.37</td><td align="center" rowspan="1" colspan="1">36.81 &#x000b1; 31.94</td><td align="center" rowspan="1" colspan="1">35.07 &#x000b1; 33.24</td><td align="center" rowspan="1" colspan="1">33.33 &#x000b1; 32.88</td><td align="center" rowspan="1" colspan="1">27.78 &#x000b1; 29.87</td><td align="center" rowspan="1" colspan="1">25.93 &#x000b1; 25.04</td><td align="center" rowspan="1" colspan="1">27.47 &#x000b1; 24.11</td><td align="center" rowspan="1" colspan="1">25.62 &#x000b1; 24.88</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Trouble with social <break/>&#x02003;contact</td><td align="center" rowspan="1" colspan="1">21.45 &#x000b1; 24.37</td><td align="center" rowspan="1" colspan="1">19.13 &#x000b1; 21.40</td><td align="center" rowspan="1" colspan="1">18.84 &#x000b1; 23.32</td><td align="center" rowspan="1" colspan="1">16.81 &#x000b1; 22.64</td><td align="center" rowspan="1" colspan="1">12.46 &#x000b1; 20.03</td><td align="center" rowspan="1" colspan="1">13.33 &#x000b1; 19.07</td><td align="center" rowspan="1" colspan="1">9.28 &#x000b1; 18.83</td><td align="center" rowspan="1" colspan="1">9.57 &#x000b1; 19.47</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Less sexuality </td><td align="center" rowspan="1" colspan="1">39.86 &#x000b1; 33.99</td><td align="center" rowspan="1" colspan="1">36.23 &#x000b1; 30.84</td><td align="center" rowspan="1" colspan="1">34.06 &#x000b1; 30.76</td><td align="center" rowspan="1" colspan="1">39.86 &#x000b1; 34.36</td><td align="center" rowspan="1" colspan="1">35.51 &#x000b1; 29.86</td><td align="center" rowspan="1" colspan="1">42.03 &#x000b1; 30.51</td><td align="center" rowspan="1" colspan="1">46.38 &#x000b1; 34.07</td><td align="center" rowspan="1" colspan="1">46.38 &#x000b1; 34.07</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Teeth</td><td align="center" rowspan="1" colspan="1">44.44 &#x000b1; 27.22</td><td align="center" rowspan="1" colspan="1">38.89 &#x000b1; 23.40</td><td align="center" rowspan="1" colspan="1">37.50 &#x000b1; 28.34</td><td align="center" rowspan="1" colspan="1">38.89 &#x000b1; 27.22</td><td align="center" rowspan="1" colspan="1">39.51 &#x000b1; 30.71</td><td align="center" rowspan="1" colspan="1">34.57 &#x000b1; 31.33</td><td align="center" rowspan="1" colspan="1">38.27 &#x000b1; 32.95</td><td align="center" rowspan="1" colspan="1">43.21 &#x000b1; 33.10</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Opening mouth</td><td align="center" rowspan="1" colspan="1">36.11 &#x000b1; 30.95</td><td align="center" rowspan="1" colspan="1">30.56 &#x000b1; 30.95</td><td align="center" rowspan="1" colspan="1">33.33 &#x000b1; 31.08</td><td align="center" rowspan="1" colspan="1">31.94 &#x000b1; 30.26</td><td align="center" rowspan="1" colspan="1">28.40 &#x000b1; 30.25</td><td align="center" rowspan="1" colspan="1">32.10 &#x000b1; 32.66</td><td align="center" rowspan="1" colspan="1">34.57 &#x000b1; 32.66</td><td align="center" rowspan="1" colspan="1">32.10 &#x000b1; 29.93</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Dry mouth</td><td align="center" rowspan="1" colspan="1">65.28 &#x000b1; 25.02</td><td align="center" rowspan="1" colspan="1">56.94 &#x000b1; 23.01</td><td align="center" rowspan="1" colspan="1">55.56 &#x000b1; 23.40</td><td align="center" rowspan="1" colspan="1">55.56 &#x000b1; 23.40</td><td align="center" rowspan="1" colspan="1">62.96 &#x000b1; 29.72</td><td align="center" rowspan="1" colspan="1">61.73 &#x000b1; 28.80</td><td align="center" rowspan="1" colspan="1">62.96 &#x000b1; 28.24</td><td align="center" rowspan="1" colspan="1">56.79 &#x000b1; 30.40</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Sticky saliva</td><td align="center" rowspan="1" colspan="1">44.44 &#x000b1; 32.10</td><td align="center" rowspan="1" colspan="1">38.89 &#x000b1; 30.56</td><td align="center" rowspan="1" colspan="1">38.89 &#x000b1; 30.56</td><td align="center" rowspan="1" colspan="1">38.89 &#x000b1; 30.56</td><td align="center" rowspan="1" colspan="1">48.15 &#x000b1; 36.20</td><td align="center" rowspan="1" colspan="1">50.62 &#x000b1; 35.05</td><td align="center" rowspan="1" colspan="1">50.62 &#x000b1; 28.30</td><td align="center" rowspan="1" colspan="1">50.62 &#x000b1; 31.17</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Coughing</td><td align="center" rowspan="1" colspan="1">25.00 &#x000b1; 22.52</td><td align="center" rowspan="1" colspan="1">23.61 &#x000b1; 23.01</td><td align="center" rowspan="1" colspan="1">25.00 &#x000b1; 24.57</td><td align="center" rowspan="1" colspan="1">25.00 &#x000b1; 24.57</td><td align="center" rowspan="1" colspan="1">29.63 &#x000b1; 31.12</td><td align="center" rowspan="1" colspan="1">19.75 &#x000b1; 24.91</td><td align="center" rowspan="1" colspan="1">17.28 &#x000b1; 16.97</td><td align="center" rowspan="1" colspan="1">18.52 &#x000b1; 19.25</td></tr><tr><td align="left" rowspan="1" colspan="1">Felt ill</td><td align="center" rowspan="1" colspan="1">33.33 &#x000b1; 20.60</td><td align="center" rowspan="1" colspan="1">28.99 &#x000b1; 25.23</td><td align="center" rowspan="1" colspan="1">24.64 &#x000b1; 27.00</td><td align="center" rowspan="1" colspan="1">24.64 &#x000b1; 25.06</td><td align="center" rowspan="1" colspan="1">30.43 &#x000b1; 28.27</td><td align="center" rowspan="1" colspan="1">31.88 &#x000b1; 30.94</td><td align="center" rowspan="1" colspan="1">36.23 &#x000b1; 28.27</td><td align="center" rowspan="1" colspan="1">33.33 &#x000b1; 22.47</td></tr></tbody></table><table-wrap-foot><fn><p>Pre: pretest (baseline); mid: midintervention test (3 months); post: posttest (6 months); FU: follow-up test (12 months).</p></fn><fn><p>Mean &#x000b1; SD presented the continuous variables.</p></fn><fn><p>The effect sizes are in partial eta-squared.</p></fn><fn><p>Group-by-time interaction, group and time effects.</p></fn><fn><p>*Significant difference at <italic>P</italic> &#x0003c; 0.05.</p></fn><fn><p>Within group (alpha adjusted to 0.008 due to six paired comparisons).</p></fn><fn><p>
<sup>
a</sup>Significant difference at <italic>P</italic> &#x0003c; 0.008 compared with the pretest values.</p></fn><fn><p>Between groups.</p></fn><fn><p>
<sup>
b</sup>Difference significant at <italic>P</italic> &#x0003c; 0.05 compared with the control group.</p></fn></table-wrap-foot></table-wrap></floats-group></article>